Mandate

Vinge has advised Lone Star Fund and Stark Group in connection with the sale of the Stark Group to CVC Capital Partners.

Headquartered in Denmark, STARK Group is a leading B2B distributor of heavy building materials for the construction industry in the Nordics and Germany, with a focus on serving professional craftsmen. The business partners with 10,000 suppliers to serve c. 235,000 customers from more than 400 locations in Denmark (incl. Greenland), Sweden, Norway, Finland, and Germany. The transaction is subject to customary conditions and approvals and is expected to close in Q2 2021.

Vinge’s team consisted of, among others, Jonas Bergström, Desirée Sjöblom, Vilhelm Rondahl and Amanda Steen (M&A), Michaela Cronemyr and Isabell Nielsen (Agreements), Frida Ställborn and Kristoffer Larson (Real Estate), Sara Strandberg and Caroline Edwall (Employment), Sofia Bergenstråhle (IP), Ludvig Wettergren and Jolinn Uhlin (Financial Arrangements), Fredrika Hjelmberg (IT), Nicklas Thorgerzon (GDPR), Lina Österberg (Permits), Tove Lövgren Frisk (Compliance) and the VDR assistant Carl Bruneheim.

 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026